A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of "BR6002" and Coadministration of "BR6002A" and "BR6002B" Under Fasting Conditions in Healthy Adult Volunteers

NCT05959486 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric or Duodenal Ulcers

Interventions

DRUG: BR6002A
DRUG: BR6002B
DRUG: BR6002

Sponsor

Boryung Pharmaceutical Co., Ltd